PATENT CLAIM ANALYSIS

Application Number: 16013059
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-12
Patent Classification: ["514", "265100"]

Abstract:
The present invention is directed to methods and compositions for inhibition of viral nucleic acid polymerases, such as RNA and DNA polymerases, and methods and compositions that are useful for treating viral infections in subjects. The methods comprise administering to the subject a therapeutically effective amount of a compound of formula I, or a pharmaceutically acceptable salt or hydrate thereof, or a composition comprising a compound of formula I, or a pharmaceutically acceptable salt or hydrate thereof, and a pharmaceutically acceptable carrier. The composition or method may optionally comprise one or more additional anti-viral agents.

Claim (Index 105):
The method of  claim 104 , wherein the virus is West Nile, yellow fever, Dengue fever, influenza A, influenza B, or Rift Valley Fever virus.

Metadata:
- Claim Count in Document: 72.0
- Percentile: 94.0
- Lexical Diversity: 1.82456
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14531471', '14890719', '14395355', '12797575', '13700049']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7463426693427142
- 35 USC 102 Novelty (BERT): 0.5566540888570072
- Combined Prediction Score: 0.7273738112941435
- Mean Citation Score: 283.657462
- Max Citation Score: 428.07938
- Similarity Product: 275.8325879789174

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test